Araceli Biosciences Inc.

New Filing
CIK: 0001975014·Other Technology·DELAWARE·Filed: Jan 15, 2025
Total Offering

$8,000,351

Amount Sold

$2,525,000

Investors

6

First Sale

Dec 31, 2024

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2022
Non-Accredited Investors
No

Related Persons

NameRole
Bruce Rhine
Related Person
William Cortelyou
Related Person
Shawn MacDonald
Related Person
Samraat Raha
Related Person
Sean O'Neill
Related Person
J. William Freytag
Related Person
Matt Beaudet
Related Person
Kevin Gabelein
Related Person
Kirk Malloy
Related Person

Company

Araceli Biosciences Inc.

7405 SW TECH CENTER DRIVE

TIGARD, OR, 97223-8080

503-853-4144

SEC Filing

0001975014-25-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free